Physician perceptions of drug utilization management: Results of a national survey

Author:

Edwards Marie Louise,Yin Perry T.,Kuehn MichaelORCID,Bratti KeithORCID,Kirson Noam,Jena Anupam B.,Howell ScottORCID

Abstract

The use of drug utilization management techniques such as formulary exclusions, prior authorizations, and step edits has risen sharply during the last decade, contributing to the growing burden on physicians and patients. Limited quantitative data exist, however, on physician perceptions of drug utilization management. A national survey was conducted between February 9 and March 30, 2021, targeting office-based physicians working in the United States to assess their perceptions on drug utilization management in their practice. Of the 742 physicians that participated in the study, over 80% reported deciding against prescribing certain treatments in anticipation of drug utilization management at least sometimes (>50% of the time). Despite utilization management having an impact on prescribing decisions, about half of physicians said that the utilization management policies they encounter rarely or never (0–25% of the time) align with clinical evidence.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Refocusing medication prior authorization on its intended purpose;JS Resneck;JAMA,2020

2. A Data Book: Healthcare Spending and the Medicare Program [Internet]. Medicare Payment Advisory Comission; 2019 [cited 2021 Jul 23]. Available from: http://www.medpac.gov/docs/default-source/data-book/jun19_databook_entirereport_sec.pdf?sfvrsn=0.

3. Has the era of slow growth for prescription drug spending ended?;M Aitken;Health Affairs.,2016

4. Skyrocketing Growth in PBM Formulary Exclusions Raises Concerns About Patient Access [Internet]. Xcenda; 2020 [cited 2021 Jul 23]. Available from: https://www.xcenda.com/insights/skyrocketing-growth-in-pbm-formulary-exclusions-raises-concerns-about-patient-access.

5. Specialty drug coverage varies across commercial health plans in the US.;JD Chambers;Health Affairs,2018

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3